We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
Cap. Flow
+$81.1M
Cap. Flow %
34.53%
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.52M
2
KDP icon
Keurig Dr Pepper
KDP
+$2.4M
3
WFC icon
Wells Fargo
WFC
+$2.19M
4
AET
Aetna Inc
AET
+$2.17M
5
PNC icon
PNC Financial Services
PNC
+$2.15M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.39M
2
ETN icon
Eaton
ETN
+$1.38M
3
CB
CHUBB CORPORATION
CB
+$1.35M
4
XEC
CIMAREX ENERGY CO
XEC
+$1.32M
5
DVA icon
DaVita
DVA
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 15.9%
2 Consumer Discretionary 14.51%
3 Industrials 13.73%
4 Financials 13.03%
5 Healthcare 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNC
726
DELISTED
GNC Holdings, Inc.
GNC
– –
-3,594
Closed -$111K
JCP
727
DELISTED
J.C. Penney Company, Inc.
JCP
– –
-41,258
Closed -$275K
DPLO
728
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-400
Closed -$14K
WCG
729
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-1,400
Closed -$109K
MDCO
730
DELISTED
Medicines Co
MDCO
– –
-2,100
Closed -$78K
GWR
731
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-16,200
Closed -$870K
INSY
732
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-3,475
Closed -$99K
IMPV
733
DELISTED
Imperva, Inc.
IMPV
– –
-1,000
Closed -$63K
EGN
734
DELISTED
Energen
EGN
– –
-1,600
Closed -$66K
PX
735
DELISTED
Praxair Inc
PX
– –
-8,500
Closed -$870K
EVHC
736
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-236
Closed -$18K
VR
737
DELISTED
Validus Hold Ltd
VR
– –
-13,400
Closed -$620K
TWX
738
DELISTED
Time Warner Inc
TWX
– –
-11,534
Closed -$746K
LQ
739
DELISTED
La Quinta Holdings Inc.
LQ
– –
-6,660
Closed -$91K
DYN
740
DELISTED
Dynegy, Inc.
DYN
– –
-24,105
Closed -$323K
TERP
741
DELISTED
TerraForm Power, Inc
TERP
– –
-1,500
Closed -$19K
MBLY
742
DELISTED
Mobileye N.V.
MBLY
– –
-13,801
Closed -$584K
KATE
743
DELISTED
Kate Spade & Company
KATE
– –
-5,448
Closed -$97K
CIE
744
DELISTED
Cobalt International Energy, Inc
CIE
– –
-1,020
Closed -$83K
YHOO
745
DELISTED
Yahoo Inc
YHOO
– –
-8,319
Closed -$277K
MENT
746
DELISTED
Mentor Graphics Corp
MENT
– –
-300
Closed -$6K
HAR
747
DELISTED
Harman International Industries
HAR
– –
-3,100
Closed -$292K
STJ
748
DELISTED
St Jude Medical
STJ
– –
-6,606
Closed -$408K
FLTX
749
DELISTED
Fleetmatics Group PLC
FLTX
– –
-2,000
Closed -$102K
RAX
750
DELISTED
Rackspace Hosting Inc
RAX
– –
-4,100
Closed -$104K
28 29
30
31 32

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.

  • Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
  • Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
  • Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
  • Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
  • Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
  • Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
  • Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.

Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.